CMH Wealth Management LLC Has $3.21 Million Holdings in Danaher Co. (DHR)

CMH Wealth Management LLC raised its position in shares of Danaher Co. (NYSE:DHR) by 7.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,285 shares of the conglomerate’s stock after purchasing an additional 1,645 shares during the period. Danaher accounts for approximately 1.9% of CMH Wealth Management LLC’s holdings, making the stock its 17th biggest position. CMH Wealth Management LLC’s holdings in Danaher were worth $3,206,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its position in shares of Danaher by 14.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,426,709 shares of the conglomerate’s stock worth $372,344,000 after buying an additional 424,317 shares in the last quarter. Martingale Asset Management L P raised its position in shares of Danaher by 0.6% during the 3rd quarter. Martingale Asset Management L P now owns 580,052 shares of the conglomerate’s stock worth $63,030,000 after buying an additional 3,402 shares in the last quarter. LPL Financial LLC raised its position in shares of Danaher by 17.8% during the 3rd quarter. LPL Financial LLC now owns 81,741 shares of the conglomerate’s stock worth $8,882,000 after buying an additional 12,337 shares in the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Danaher during the 3rd quarter worth about $212,000. Finally, Point72 Asset Management L.P. raised its position in shares of Danaher by 1,243.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 268,700 shares of the conglomerate’s stock worth $29,197,000 after buying an additional 248,700 shares in the last quarter. 77.58% of the stock is owned by hedge funds and other institutional investors.

DHR stock traded down $1.65 during trading hours on Monday, hitting $129.98. The company’s stock had a trading volume of 1,596,387 shares, compared to its average volume of 2,547,479. The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $94.21 billion, a price-to-earnings ratio of 28.76, a P/E/G ratio of 2.40 and a beta of 1.04. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $134.50.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $5.40 billion during the quarter, compared to the consensus estimate of $5.33 billion. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.19 earnings per share. On average, research analysts expect that Danaher Co. will post 4.79 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.52%. This is an increase from Danaher’s previous quarterly dividend of $0.16. The ex-dividend date is Thursday, March 28th. Danaher’s payout ratio is currently 15.04%.

A number of analysts have commented on the stock. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research report on Tuesday, April 9th. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $140.00 target price on shares of Danaher in a report on Monday, March 4th. Needham & Company LLC reiterated a “buy” rating and issued a $138.00 target price (up from $114.00) on shares of Danaher in a report on Thursday, February 28th. Jefferies Financial Group boosted their target price on shares of Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, Deutsche Bank boosted their target price on shares of Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $125.46.

In other Danaher news, CAO Robert S. Lutz sold 15,000 shares of the business’s stock in a transaction that occurred on Sunday, February 24th. The shares were sold at an average price of $127.00, for a total value of $1,905,000.00. Following the completion of the sale, the chief accounting officer now directly owns 22,251 shares of the company’s stock, valued at $2,825,877. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Walter G. Lohr sold 10,578 shares of the business’s stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total transaction of $1,341,819.30. Following the completion of the sale, the director now directly owns 20,691 shares of the company’s stock, valued at $2,624,653.35. The disclosure for this sale can be found here. Insiders sold 183,150 shares of company stock valued at $23,279,637 over the last three months. Insiders own 11.90% of the company’s stock.

WARNING: “CMH Wealth Management LLC Has $3.21 Million Holdings in Danaher Co. (DHR)” was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/04/15/cmh-wealth-management-llc-has-3-21-million-holdings-in-danaher-co-dhr.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: Mutual Funds

Receive News & Ratings for Danaher Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher and related companies with MarketBeat.com’s FREE daily email newsletter.